<DOC>
	<DOCNO>NCT01122043</DOCNO>
	<brief_summary>The purpose study determine clinical safety efficacy EndoGlide donor insertion device DSAEK surgery . The investigator hypotheses Endoglide cause less endothelial damage compare investigator previous technique glide insertion low complication rate previous device . Hence investigator aim evaluate surgical efficacy EndoGlide enable consistent double coil donor lenticule DSAEK surgery minimal endothelial touch . Evaluate ease insertion EndoGlide 4 4.5mm scleral tunnel wound . Evaluate ability EndoGlide consistently effect complete wound sealing , stabilize anterior chamber AC maintainer position . Evaluate ease donor pull-through EndoGlide chamber AC evaluate spontaneous uncoil donor AC . Evaluate clinical efficacy safety outcome EndoGlide assist DSAEK surgery study patient corneal decompensation require DSAEK surgery , term postoperative visual acuity , primary graft failure rate , donor dislocation rate , endothelial cell loss , deturgescence host cornea donor lenticule measure corneal thickness parameter Visante AS-OCT . The investigator perfprm prospective Phase II clinical trial use EndoGlide donor insertion 100 corneal patient refer SNEC Corneal Clinics study investigator moderate degree corneal decompensation variety disorder require DSAEK corneal transplantation surgery , without concurrent cataract surgery , restore visual acuity .</brief_summary>
	<brief_title>The SNEC DSAEK EndoGlide Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Corneal Edema</mesh_term>
	<criteria>1. patient present corneal decompensation bullous keratopathy require corneal transplantation visual restoration pain relief 2 . Clinical diagnosis include postsurgical form corneal decompensation ( form pseudophakic aphakic bullous keratopathy include TASS irreversible Descemets detachment ) , postlaser corneal decompensation , Fuchs ' form endothelial dystrophy , traumatic corneal decompensation , postinflammatory corneal decompensation , etc . 3 . Mild moderate form corneal decompensation 4. patient agree study participation follow full inform consent 5. patient agree adhere standard SNEC clinical DSAEK protocol term pre postoperative investigation followup visit 12 month 1 . Severe form late stage presentation corneal decompensation severe corneal stromal scarring , unsuitable DSAEK surgery appose penetrate keratoplasty 2. patient complex anterior segment complication preclude successful DSAEK procedure 3. patient unkeen participate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Endoglide</keyword>
	<keyword>Endothelial Keratoplasty</keyword>
	<keyword>Donor Insertion</keyword>
	<keyword>DSAEK</keyword>
	<keyword>Corneal Transplant</keyword>
	<keyword>Patients Bullous Keratopathy</keyword>
</DOC>